Published on in Vol 5, No 2 (2021): February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25184, first published .
Preliminary Screening for Hereditary Breast and Ovarian Cancer Using a Chatbot Augmented Intelligence Genetic Counselor: Development and Feasibility Study

Preliminary Screening for Hereditary Breast and Ovarian Cancer Using a Chatbot Augmented Intelligence Genetic Counselor: Development and Feasibility Study

Preliminary Screening for Hereditary Breast and Ovarian Cancer Using a Chatbot Augmented Intelligence Genetic Counselor: Development and Feasibility Study

Ann Sato   1 , MSc ;   Eri Haneda   1 , MSc ;   Nobuyasu Suganuma   2 , MD, PhD ;   Hiroto Narimatsu   1, 3, 4 , MD, PhD

1 Department of Genetic Medicine, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

2 Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

3 Cancer Prevention and Cancer Control Division, Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa, Japan

4 Graduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Kanagawa, Japan

Corresponding Author:

  • Hiroto Narimatsu, MD, PhD
  • Department of Genetic Medicine
  • Kanagawa Cancer Center
  • 2-3-2 Nakao, Asahi-ku
  • Yokohama, Kanagawa, 241-8515
  • Japan
  • Phone: 81 045-520-2222
  • Fax: 81 045-520-2216
  • Email: hiroto-narimatsu@umin.org